Transcarent Stock

HealthTech

Looking to sell Transcarent stock or options?

Founded: 2018Funding to Date: $343M

Transcarent is the creator of a consumer-focused health and care platform intended to assist in making cost-effective decisions and achieving improved outcomes. Transcarent uses a mix of software, a technology stack, and data science to equip consumers with valuable information and access. By directly linking them to a comprehensive ecosystem of high-value providers and health solutions, Transcarent ensures customers can exercise choice and transparency. This allows them to tackle a wide range of challenges faced in today's healthcare system effectively.

Investors include:

Further Key Investors:

Merck Global Health Innovation Fund, Ally Bridge Group, Wasson Enterprise, 50 South Capital Advisors, Intermountain Healthcare, Kinnevik, Northwell Holdings, Intermountain Ventures, 7wireVentures, Rush University System for Health, GreatPoint Ventures, Human Capital, General Catalyst, Threshold Ventures, Alta Partners, Jove Equity Partners, Leaps by Bayer.

Looking to sell Transcarent Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you